Chargement en cours...
Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress
Many now believe the holy grail for the next stage of therapeutic advance surrounds the development of disease-modifying approaches aimed at intercepting the year-on-year neurodegenerative decline experienced by most patients with Parkinson’s disease (PD). Based on recommendations of an internationa...
Enregistré dans:
| Publié dans: | J Parkinsons Dis |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
IOS Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5676977/ https://ncbi.nlm.nih.gov/pubmed/29036837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-171203 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|